Ian Moon

Ian Moon serves as a Contract Specialist within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic procurement of critical scientific and operational resources. He manages a diverse portfolio of acquisitions focused on laboratory diagnostics, biomedical research infrastructure, and data-driven public health systems, ensuring timely delivery of mission-critical capabilities. His work directly enables CDC’s response to infectious disease threats by facilitating the acquisition of advanced diagnostic tools, analytical platforms, and research support services essential for national surveillance and emergency preparedness. Moon maintains consistent working relationships with key contractors including General Dynamics Information Technology, GlaxoSmithKline, New York City Health & Hospitals Corp, MRIGLOBAL, and Cepheid. These partnerships span contract types ranging from research and development to equipment leasing and technical services, reflecting a balanced approach to engaging both large institutional providers and specialized scientific vendors. His procurement strategy emphasizes reliability, technical compliance, and operational scalability to meet the CDC’s dynamic public health demands. Moon’s contracting activity reflects a strong preference for open competition, with 100% of awards issued under no set-aside provisions. This indicates a focus on technical merit and capability over socioeconomic categorization, aligning with the agency’s need for high-complexity, mission-critical solutions where specialized expertise takes precedence over small business set-asides. While socioeconomic preferences are not leveraged, his process remains fully compliant with federal acquisition regulations and emphasizes transparency and competition. His primary procurement focus lies in NAICS 532490 (commercial and industrial equipment leasing), supporting the acquisition of specialized laboratory and diagnostic infrastructure, and NAICS 611310 and 611710, which encompass academic and research support services. This reflects deep expertise in procuring high-end analytical equipment, biosafety systems, and institutional research partnerships critical to advancing infectious disease detection and public health science.